PFIZER has agreed to pay
US$490.9 million to resolve claims
relating to illegal marketing of
kidney transplant drug Rapamune
(sirolimus) which it acquired when
it took over Wyeth.
According to the US Department
of Justice, Wyeth trained its
sales staff to promote Rapamune
for unapproved uses between
1998 and 2009, as well as paying
bonuses to encourage these sales.
The DoJ said it was a “systemic,
corporate effort to seek profit over
safety”.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Aug 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Aug 13
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.